Haifeng Li – Trademark Portfolio
Entity Type: 01
Haifeng Li owns a portfolio of 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GUECW, LIFLARMED, and MOREKA.PET. Of these, 3 are registered and 4 are pending. The portfolio spans 7 Nice Classification classes, led by Class 21 (Housewares) and Class 9 (Computers & Electronics). Headquartered in Guangdong.
No. 40, Liwu Village, Liantan Town
Yunan County, Yunfu
Guangdong 527125 , CN
Showing of trademarks Trademarks
Trademark Classifications
Haifeng Li's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Haifeng Li have?
Haifeng Li has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending, 1 abandoned.
What trademark classes does Haifeng Li file in?
Haifeng Li files trademarks across 7 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are Haifeng Li's most well-known trademarks?
Haifeng Li's registered trademark portfolio includes well-known marks such as GUECW, LIFLARMED, and MOREKA.PET. These are among 3 currently registered trademarks in the portfolio.
What is Haifeng Li's trademark registration success rate?
Haifeng Li has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 4 applications are pending review.